Search the Newsreel

Once Upon A Farm (OFA) Stock Premium Hinges On Growth Path

Once Upon A Farm PBC (OFA) reported increased Q2 2026 revenue of US$85.4 million, up from US$60.0 million year-over-year, while narrowing its net loss from US$9.04 million to US$4.95 million. Despite this progress, the company still trades at a premium sales multiple, raising questions …

Concentra Group Holdings Parent, Inc. Stock 12‑Month Price Target Raised to $34.62, Implies 13% Upside

The average 12-month price target for Concentra Group Holdings Parent, Inc. (CON) stock has been raised to $34.62, up from $33.38, according to estimates from 8 analysts. This updated target implies a 13% potential upside based on the Aug. 6 closing price, with forecasts …

Pyxis Oncology Inc (PYXS) Stock News Today

This article from TradingKey provides current stock news for Pyxis Oncology Inc (PYXS). It lists the company's stock price, market capitalization, and indicates that more news, earnings, and analyst ratings will be updated soon. The content serves as a placeholder for ongoing updates regarding …

CG Oncology (NASDAQ:CGON) Posts Earnings Results, Misses Expectations By $0.24 EPS

CG Oncology (NASDAQ:CGON) reported a wider-than-expected quarterly loss of $0.90 per share, missing consensus estimates by $0.24, despite revenue of $1.16 million surpassing expectations. The stock saw a slight increase to $75.10, near its 52-week high, and maintains a "Moderate Buy" consensus rating with …

NeOnc Technologies Holdings Inc (NTHI) Stock News Today

This article provides current stock information for NeOnc Technologies Holdings Inc (NTHI), including its stock price, market cap, and a note that more news will be available soon. It highlights that the company's stock is trading at $3.500 with no change and has a …

ONC|Beigene Ltd|Price:359.030|Chg%:+10.760

This article provides a comprehensive stock analysis of Beigene Ltd (ONC), highlighting its strong fundamentals, high growth potential, and relatively fair valuation within the Biotechnology & Medical Research industry. It notes high institutional ownership and recent "Buy" ratings from analysts. The analysis also covers …

CONCORD ENVIRO SYSTEMS LTD. Share Price Today Down 6%

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Treace Medical Concepts (NASDAQ:TMCI) announced its quarterly earnings, reporting an adjusted loss of $0.24 per share, surpassing the consensus estimate of a $0.30 loss, with revenues of $45.38 million beating the $44.02 million forecast. The company raised its 2026 revenue guidance to $204 million–$212 …

Treace Medical Concepts earnings beat by $0.06, revenue topped estimates

Treace Medical Concepts (NASDAQ: TMCI) reported a second-quarter EPS of $-0.24, surpassing the analyst estimate of $-0.30 by $0.06. The company's revenue for the quarter reached $45.4 million, exceeding the consensus estimate of $43.94 million. Despite a 117.91% increase in its stock price over …

The Oncology Institute, Inc. (STLN) Income Statement

The article provides the income statement for The Oncology Institute, Inc. (STLN) showing financial data for annual and quarterly periods up to 2025-12-31, with a TTM (trailing twelve months) column. Key financial metrics such as total revenue, gross profit, operating income, and net income …

The Oncology Institute, Inc. $TOI Shares Bought by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership significantly increased its stake in The Oncology Institute, Inc. ($TOI) by 169.3% in the first quarter, now owning 419,423 shares valued at approximately $1.29 million. Other institutional investors like Goldman Sachs and Geode Capital Management also made notable changes to …

Oncology Institute Q2 Earnings Call Highlights

Oncology Institute reported strong Q2 revenue growth, positive adjusted EBITDA, and rebranded as Starling Oncology to reflect its evolution into a national value-based oncology provider. The company expanded its value-based contracts, adding new agreements in Nevada, Oregon, and California, which are expected to significantly …

Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...

Treace Medical Concepts Inc (TMCI) reported a 4% revenue decline to $45.4 million in Q2 2026, though adjusted EBITDA loss narrowed and cash usage significantly decreased. The company is experiencing increased adoption of new bunion systems and expects improved performance in the latter half …

Treace Medical Concepts Releases Q2 2026 Financial Results

Treace Medical Concepts, Inc. (TMCI) reported a narrower Q2 2026 loss per share of -$0.24, beating the -$0.30 estimate by 20.0%. The company's revenue for the quarter was $45.4 million, representing a 4.0% year-over-year decrease. Management projects full-year revenue to be between $204.0 million …

Concentra Group Holdings Parent Inc (CON) (Q2 2026) Earnings Call Highlights: Strong Revenue ...

This article first appeared on GuruFocus. Total Revenue: $606 million in Q2 2026, a 10% increase year-over-year from $550.8 million. Core Revenue Growth: Excluding Pivot acquisition, revenue was $589.1 million, an 8% increase over the prior year. Occupational Health Segment Revenue: $553.5 million, up …

Insider Ambaw Bellete plans CGON (CGON) stock sale after large prior trades

Ambaw Bellete, an insider at CG Oncology, Inc. (CGON), has filed a Form 144 indicating an intent to sell up to 9,250 shares of common stock on August 7, 2026, through Morgan Stanley Smith Barney LLC. This filing also details several significant common stock …

Once Upon a Farm, PBC Q2 2026: Revenue $85.4M, EPS $(0.12) — 10-Q Summary

Once Upon a Farm, PBC reported strong financial results for Q2 2026, with revenue reaching $85.4M, a 42% increase year-over-year, and a significantly narrower net loss of $4.95M. The company also improved its diluted EPS to $(0.12) from $(1.36) in the prior-year quarter. This …

Royal Bank Of Canada Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price

Once Upon a Farm Lifts 2026 Outlook Again as Q2 Revenue Surges 42%

Once Upon a Farm (NYSE: OFRM) reported stronger-than-expected second-quarter 2026 results, with net sales surging over 42% year-over-year to $85.4 million. The company raised its full-year revenue guidance for the second consecutive quarter, now expecting $325 million to $335 million, driven by strong growth …

Cardiff Oncology Inc (CRDF) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cardiff Oncology Inc (CRDF) has an earnings forecast score of 7.25, ranking 296 out of 387 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $10.00, with a high of $19.00 and a low of $3.50, based on …

Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates

JPMorgan Chase & Co. Boosts Once Upon A Farm (NYSE:OFRM) Price Target to $26.00

JPMorgan Chase & Co. has increased its price target for Once Upon A Farm (NYSE:OFRM) to $26.00 from $22.00, reiterating an "overweight" rating. This new target suggests a potential upside of approximately 56% from the stock's current price. The company recently exceeded earnings expectations, …

Ponce Financial Group Inc (PDLB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Ponce Financial Group Inc (PDLB) has an earnings forecast score of 8.00, ranking 53rd in the Banking Services industry, with an average price target of $18.50. One analyst rates the stock as "Buy," predicting a 19.11% upside. The company's EPS for the previous quarter …

Concentra Group Holdings Parent (NYSE:CON) Reaches New 12-Month High After Earnings Beat

Concentra Group Holdings Parent (NYSE:CON) hit a new 52-week high after reporting better-than-expected quarterly earnings, with EPS of $0.52 against a $0.42 consensus and revenue of $606.03 million, up 10% year-over-year. Analysts remain largely positive, with seven rating the stock a "Buy" and one …

Renaissance Technologies LLC Sells 307,595 Shares of Cullinan Therapeutics, Inc. $CGEM

Renaissance Technologies LLC has reduced its stake in Cullinan Therapeutics (NASDAQ:CGEM) by 48.7% during the first quarter, selling 307,595 shares and retaining 324,111 shares valued at $4.6 million. Despite this sale, institutional investors collectively hold 86.31% of the company's stock, and analysts maintain a …

Truist Financial Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price

Earnings call transcript: Concentra Q2 2026 profit, guidance raise lift shares 11%

Concentra Group Holdings Parent Inc. reported strong Q2 2026 results with a 10% increase in revenue to $606 million and adjusted EPS of $0.52, leading to an 11% surge in shares. The company also raised its full-year 2026 guidance for revenue, adjusted EBITDA, and …

Kura Oncology, Inc. (KURA) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive financial data for Kura Oncology, Inc. (KURA), including its current stock price, historical performance, key statistics, earnings trends, and analyst ratings. It also offers an overview of the company's biopharmaceutical operations, focusing on its cancer treatment drug development.

Deutsche Bank Adjusts Once Upon A Farm PT to $20 From $17, Maintains Hold Rating

Deutsche Bank has increased its price target for Once Upon A Farm, PBC (OFRM) to $20 from $17, while maintaining a "Hold" rating on the stock. This adjustment comes shortly after Once Upon A Farm reported its second-quarter earnings and raised its full-year 2026 …

Concentra Group Holdings Parent, Inc. (CON) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive information on Concentra Group Holdings Parent, Inc. (CON) stock, including its current price, historical data, financial overview, and analyst insights. The stock closed at $34.06 on August 7, 2026, up 11.53%, with significant year-to-date and one-year returns. The …

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

BofA Adjusts Price Target on CG Oncology to $88 From $87

BofA Securities has raised its price target for CG Oncology (CGON) shares to $88 from $87, while maintaining a Buy rating. This adjustment follows a previous price target revision by RBC, which lowered its target to $79 from $81. The article highlights recent news …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology, Inc. announced that its Compensation Committee granted inducement awards consisting of nonstatutory stock options to purchase 104,500 shares of common stock to six new employees. These grants were made on August 3, 2026, under the Company’s 2023 Inducement Option Plan, as amended, …

Treace Medical Q2 revenue falls 4 percent to $45.4 million

Six New Employees Receive Kura Oncology Options at $9.19

Kura Oncology (Nasdaq: KURA) has granted inducement awards of nonstatutory stock options to six new employees, totaling 104,500 shares. The options have an exercise price of $9.19 per share, matching the closing price on August 3, 2026, and will vest over four years. These …